Trial Profile

Evaluation of Natural Human Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu in Perth, Western Australia.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha-2a (Primary)
Indications Common cold; Influenza virus infections
Focus Therapeutic Use
Sponsors Ainos; Amarillo Biosciences

Most Recent Events

09 Apr 2010 The final report of the results from this trial has been submitted to the State Health Research Advisory Council of the DOH, Western Austrlia, and have been published on the Amarillo Biosciences website according to an Amarillo Biosciences media release.
16 Feb 2010 According to an Amarillo Biosciences media release, a substudy in older participants indicated a benefit in preventing influenza-like illness.
05 Feb 2010 Status changed from active, no longer recruiting to completed, according to an Amarillo Biosciences media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com